Enzo Biochem(us:ENZ)
0.3400
-8.11%
Updated on 2025-04-02
Open:0.3400
Close:0.3400
High:0.3600
Low:0.3100
Prev Close:0.3700
Volume:704396.00
Turnover:233477.61
Turnover Ratio:1.34%
Shares:52.40M
MarketCap:17.82M
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-03-31 | 51 | 13822893 | 26.98% | 6 | 3 | 21 |
| 2023-12-31 | 48 | 16355323 | 32.39% | 9 | 8 | 12 |
| 2023-09-30 | 50 | 16536710 | 33.08% | 4 | 7 | 20 |
| 2023-06-30 | 57 | 18838041 | 37.88% | 5 | 9 | 23 |
| 2023-03-31 | 62 | 19833533 | 39.94% | 10 | 6 | 26 |
| 2022-12-31 | 55 | 18770197 | 38.53% | 8 | 10 | 16 |
| 2022-09-30 | 56 | 20464472 | 42.00% | 2 | 6 | 18 |
| 2022-06-30 | 57 | 21091661 | 43.29% | 6 | 9 | 16 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-03-31 | Harbert Fund Advisors, Inc. | 5175913 | 10.10% | 0 | |
| 2024-03-31 | Renaissance Technologies Llc | 2435129 | 4.75% | -44066 | -1.78% |
| 2024-03-31 | Vanguard Group Inc | 1876622 | 3.66% | 0 | |
| 2024-03-31 | Tang Capital Management Llc | 1260013 | 2.46% | -439987 | -25.88% |
| 2024-03-31 | Blackrock Inc. | 953991 | 1.86% | 324 | 0.03% |
| 2024-03-31 | Dimensional Fund Advisors Lp | 655795 | 1.28% | -73887 | -10.13% |
| 2024-03-31 | Geode Capital Management, Llc | 337856 | 0.66% | 0 | |
| 2024-03-31 | Rbf Capital, Llc | 250359 | 0.49% | 0 | |
| 2024-03-31 | Bridgeway Capital Management, Llc | 227100 | 0.44% | 0 | |
| 2024-03-31 | State Street Corp | 154139 | 0.30% | -12900 | -7.72% |
About
Enzo Biochem, Inc. is an integrated diagnostics, clinical lab, and life sciences company, which engages in the manufacture, development and market of products and tools for clinical research, translational research, drug development and bioscience research. The company was founded by Elazar Rabbani, Barry W. Weiner and Shahram K. Rabbani in August 1976 and is headquartered in New York, NY.
Address:81 Executive Boulevard,Suite 3,Farmingdale
Website:http://www.enzo.com
Market Movers